0001209191-22-005689.txt : 20220131
0001209191-22-005689.hdr.sgml : 20220131
20220131173315
ACCESSION NUMBER: 0001209191-22-005689
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220131
DATE AS OF CHANGE: 20220131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunkel Lori Anne
CENTRAL INDEX KEY: 0001536368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30347
FILM NUMBER: 22575378
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURIS INC
CENTRAL INDEX KEY: 0001108205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043505116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING C, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-503-6500
MAIL ADDRESS:
STREET 1: 128 SPRING STREET
STREET 2: BUILDING C, SUITE 500
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0001108205
CURIS INC
CRIS
0001536368
Kunkel Lori Anne
128 SPRING STREET
BUILDING C - SUITE 500
LEXINGTON
MA
02421
1
0
0
0
Non Qualified Stock Option
3.19
2022-01-31
4
A
0
85000
0.00
A
2032-01-30
Common stock
85000
85000
D
Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 31, 2023), subject to the director's continued service with the Company.
/s/ William Steinkrauss, Attorney-in-fact
2022-01-31